Aldose reductase inhibitor zopolrestat restores allergic hyporesponsiveness in alloxan-diabetic rats

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 173-178

  Carvalho, Vinicius F ^a   Barreto, Emiliano O ^a,b   Serra, Magda F ^a   Cordeiro, Renato S B ^a   Martins, Marco A ^a   Fortes, Zuleica Bruno ^c   e Silva, Patrícia M R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c Instituto de Ciencias Biomedicas   (Brazil)

Author keywords

Aldose reductase; Allergy; Diabetes; Mast cells

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ALLOXAN; ALUMINUM HYDROXIDE; ANTIGEN; CORTICOSTERONE; IMMUNOGLOBULIN E; OVALBUMIN; POLYOL; ZOPOLRESTAT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALLERGY; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DESENSITIZATION; DIET RESTRICTION; DRUG EFFECT; ENZYME MECHANISM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; INFLAMMATION; MALE; MAST CELL DEGRANULATION; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RAT; RAT STRAIN; SENSITIZATION; SIGNAL TRANSDUCTION;

ALDEHYDE REDUCTASE; ALLOXAN; ALUMINUM HYDROXIDE; ANIMALS; BENZOTHIAZOLES; CELL COUNT; CELL DEGRANULATION; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; HYPERSENSITIVITY; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN G; INSULIN; MALE; MAST CELLS; OVALBUMIN; PHTHALAZINES; PLEURAL CAVITY; PROTEINS; RATS; RATS, WISTAR;

EID: 33749038887     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.037     Document Type: Article

References (30)

1. Akamine E.H., Hohman T.C., Nigro D., Carvalho M.H., de Cassia Tostes R., and Fortes Z.B. Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes. J. Pharmacol. Exp. Ther. 304 (2003) 1236-1242
2. Barreto E.O., Carvalho V.F., Lagante V., Lugnier C., Cordeiro R.S., Martins M.A., and E Silva P.M. Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes. Int Immunopharmacol. 4 (2004) 755-762
3. Barreto E.O., Carvalho V.F., Oliveira M.S., Bertho A.L., Barja-Fidalgo T.C., Cordeiro R.S.B., Martins M.A., and Silva P.M.R. High levels of 348 filamentous actin and apoptosis correlate with mast cell refractoriness under 349 alloxan-evoked diabetes. Life Sci. 79 (2006) 1194-1202
4. Bell G.I., and Polonsky K.S. Diabetes mellitus and genetically programmed defects in-cell function. Nature 414 (2001) 788-791
5. Boland O.M., Blackwell C.C., Clarke B.F., and Ewing D.J. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with Diabetes mellitus. Diabetes 42 (1993) 336-340
6. Bontini N., and Fontana L. Asthma and diabetes. Lancet 354 (1999) 515-516
7. Carvalho V.F., Barreto E.O., Diaz B.L., Serra M.F., Azevedo V., Cordeiro R.S., Martins M.A., and Silva P.M. Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glucocorticoids. Eur. J. Pharmacol. 472 (2003) 221-227
8. Casacó A., Carvajal D., and Tolón Z. Diabetes-induced rat hyposensitivity to compound 48/80. Can. J. Physiol. Pharm. 69 (1991) 886-888
9. Chan O., Inouye K., Vranic M., and Matthews S.G. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143 (2002) 1761-1768
10. Cruz J.M., Oliveira M.A., Hohman T.C., and Fortes Z.B. Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes. Eur. J. Pharmacol. 391 (2000) 163-174
11. Diaz B.L., Serra M.F., Alves A.C., Pires A.L., Correa F.M., Cordeiro R.S., Martins M.A., and Silva P.M. Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. Int. Arch. Allergy Immunol. 111 (1996) 36-43
12. Diaz B.L., Serra M.F., Barreto E.O., Cordeiro R.S.B., Martins M.A., and Silva P.M.R. Antigen-induced pleural eosinophilia is suppressed in diabetic rats: role of corticosteroid hormones. Mem. Inst. Oswaldo Cruz 92 (1997) 219-222
13. de Oliveira Barreto E., Frias Carvalho V., Diaz B.L., Balduino A., Cordeiro R.S., Martins M.A., and Rodrigues e Silva P.M. Adoptive transfer of mast cells abolishes the inflammatory refractoriness to allergen in diabetic rats. Int. Arch. Allergy Immunol. 131 (2003) 212-220
14. Fortes Z.B., Becker C., Oliveira M.A., and Scivoletto R. Influence of aldose reductase inhibition on the microvascular reactivity in experimental diabetes. Gen. Pharmacol. 27 (1996) 917-921
15. Ghizzoni L., Vanelli M., Virdis R., Alberini A., Volta C., and Bernasconi S. Adrenal steroid and adrenocorticotropin responses to human corticotropin-releasing hormone stimulation test in adolescents with type I diabetes mellitus. Metabolism 42 (1993) 1141-1145
16. Greene D.A., Arezzo J.C., and Brown M.B. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 53 (1999) 580-591
17. Inskeep P.B., Reed A.E., and Ronfeld R.A. Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats. Pharm. Res. 8 (1991) 1511-1515
18. Justo P., Sanz A.B., Egido J., and Ortiz A. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 54 (2005) 2424-2429
19. Lima M.C., Martins M.A., Perez S.A., Peixoto J.M., Silva P.M., and Cordeiro R.S. Kinetics of pleural exudation and cellular alterations induced by antigen in actively sensitized rats. Braz. J. Med. Biol. Res. 23 (1990) 857-860
20. Malhotra A., Kang B.P., Hashmi S., and Meggs L.G. PKCepsilon inhibits the hyperglycemia-induced apoptosis signal in adult rat ventricular myocytes. Mol. Cell. Biochem. 268 (2005) 169-173
21. Matsuura K., Deyashiki Y., Bunai Y., Ohya Y., and Hara A. Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands. Arch. Biochem. Biophys. 328 (1996) 265-271
22. McMullen M.E., Bryant P.W., Glembotski C.C., Vincent P.A., and Pumiglia K.M. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J. Biol. Chem. 280 (2005) 20995-21003
23. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
24. Naruse K., Nakamura J., Hamada Y., Nakayama M., Chaya S., Komori T., Kato K., Kasuya Y., Miwa K., and Hotta N. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp. Eye Res. 71 (2000) 309-315
25. Olesen A.B., Juul S., Birkebaek N., and Thestrup-Pedersen K. Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet 357 (2001) 1749-1752
26. Ptak W., Rewicka M., Strzyzewska J., and Kollat M. Alleviation of IgE-mediated immune reactions in hypoinsulinaemic and hyperglycaemic mice. Clin. Exp. Immunol. 52 (1983) 54-60
27. Ramana K.V., Friedrich B., Bhatnagar A., and Srivastava S.K. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J. 17 (2003) 315-317
28. Tomlinson D.R., Stevens E.J., and Diemel L.T. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol. Sci. 15 (1994) 293-297
29. Wemuth B., and Monder C. Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity. Eur. J. Biochem. 131 (1983) 423-426
30. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50 (1998) 21-33